Employers can use Lilly's platform to connect with different third-party program administrators that help manage obesity treatment benefits and costs.
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the U.S., targeting a major barrier to access for patients.
Lilly and its chief rival, Novo Nordi… [+3520 chars]
